Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Biological Chemistry|November 30, 2006
Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogsCecilia Carnrot, Susan R Vogel, Youngjoo Byun, et al.Bioorganic & Medicinal Chemistry|September 1, 2004
Synthesis of ethyleneoxide modified 3-carboranyl thymidine analogues and evaluation of their biochemical, physicochemical, and structural propertiesJayaseharan Johnsamuel, Nisha Lakhi, Ashraf S Al-Madhoun, et al.Bioconjugate Chemistry|January 22, 2004
Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapyGong Wu, Rolf F Barth, Weilian Yang, et al.Anti-Cancer Agents in Medicinal Chemistry|March 15, 2006
Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapyGong Wu, Rolf F Barth, Weilian Yang, et al.Journal of Medicinal Chemistry|February 18, 2005
Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapyYoungjoo Byun, Junhua Yan, Ashraf S Al-Madhoun, et al.Bioconjugate Chemistry|May 16, 2002
Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapyXing Q Pan, Huaqing Wang, Supriya Shukla, et al.Cancer Research|November 20, 2002
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomasWeilian Yang, Rolf F Barth, Dianne M Adams, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 19, 2015
Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Robin J Nakkula, et al.Pharmaceutical Research|November 12, 2002
Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapyJennifer J Sudimack, Dianne Adams, Joan Rotaru, et al.Cancer Research|September 3, 2004
Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumorsRolf F Barth, Weilian Yang, Ashraf S Al-Madhoun, et al.Pageof 6